Friday, June 27, 2014

FDA OKs MannKind's Inhaled Insulin

The FDA approved Afrezza, a rapid-acting inhaled insulin made by MannKind, to improve glycemic control in adults with diabetes.



from WSJ.com: US Business http://ift.tt/1qRaFfq

via IFTTT

No comments:

Post a Comment